# ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

> **NCT01759290** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1800 (actual)

## Conditions studied

- Chronic Total Occlusion of Coronary Artery
- Coronary Occlusion
- Coronary Artery Disease
- Coronary Artery Restenosis
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Restenosis

## Interventions

- **DEVICE:** Absorb Bioresorbable Vascular Scaffold

## Key facts

- **NCT ID:** NCT01759290
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 1800 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01759290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01759290, "ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01759290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*